First-In-Human Study of EOS884448 in Participants with Advanced Cancers.
Clinical trial NCT04335253 · COMPLETED
Trial details
- NCT number
- NCT04335253
- Sponsor
- iTeos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2022-04-07
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.